Huttig Bldg Products (HBP) 3.86 $HBP
Huttig Building Products, Inc. Announces Second Quarter 2014 Results
Marketwire - Thu Jul 31, 5:01AM CDT
Huttig Building Products, Inc. (Huttig, or the Company) (NASDAQ: HBP), a leading domestic distributor of millwork, building materials and wood products, today reported financial results for the second quarter ended June 30, 2014.
Helix BioPharma Corp. Appoints New Independent Chair of the Board
Marketwire Canada - Mon Jul 21, 8:15AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced the appointment of Mr. Yvon Bastien as the new Chair of the board effective July 17, 2014. Mr. Bastien has served as an independent director of the Company since December 2013 and remains the Chair of the board's Governance & Compensation Committee. Mr. Robert Verhagen has served as Interim Chair since December 2013 and remains a Director of the Company and President and CEO.
Helix BioPharma Corp. Initiates Enrollment for Ninth Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47
Marketwire - Tue Jul 15, 7:32AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced the opening of patient screening for the ninth dose level cohort in its ongoing Phase I/II clinical safety, tolerability and preliminary efficacy study of L-DOS47 in Poland ("LDOS002"
. This follows completion of the first treatment cycle in the three patients enrolled in the eighth dose level cohort, in which L-DOS47 therapy was well tolerated, as reviewed by the Trial Steering Committee.
Helix BioPharma Corp. Announces Completion of Private Placement
Marketwire - Fri Jul 11, 7:00AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has completed a private placement with net proceeds in excess of CAD5.4 million, after fees and expenses associated with the placement.
Helix BioPharma Corp. Announces the Receipt of Subscription Agreements for a Net CAD5.4 Million Private Placement
Marketwire Canada - Mon Jul 07, 6:25AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has received private placement subscription agreements for common shares and warrants for aggregate net proceeds in excess of CAD5.4 million after expected expenses. Proceeds of the placement will be used for working capital to support the Company's expanding clinical trial initiatives.
Huttig Building Products, Inc. Set to Join Russell Microcap Index
Marketwire - Thu Jun 26, 3:00PM CDT
Huttig Building Products, Inc. (NASDAQ: HBP) is set to join the Russell Microcap(R) Index when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 27, according to a preliminary list of additions posted June 13 on www.russell.com/indexes.
GE Capital, Corporate Finance serves as administrative agent on USD160m credit facility for Huttig Building Product
M2 - Thu Jun 19, 3:05AM CDT
GE Capital, Corporate Finance announced on Wednesday that it is serving as administrative agent on a USD160m revolving credit facility for Huttig Building Product Inc (Nasdaq:HBP), a wholesale distributor of millwork, building materials and wood products.
GE Capital Is Administrative Agent on $160 Million Credit Facility for Huttig Building Products Inc.
Business Wire - Wed Jun 18, 7:00AM CDT
GE Capital, Corporate Finance today announced it is serving as administrative agent on a $160 million revolving credit facility for Huttig Building Product Inc. (NASDAQ:HBP). The new facility refinances existing debt and provides an additional $40 million in financing to support future growth. GE Capital Markets served as co-lead arranger.
Helix BioPharma Corp. Announces Fiscal Q3 2014 Results
Marketwire - Thu Jun 12, 8:02AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today announced financial results for the three and nine-month periods ended April 30, 2014 and 2013.
Huttig Building Products, Inc. Amends and Extends Credit Facility -- Increases Capacity to $160 Million
Marketwire - Thu May 29, 5:01AM CDT
Huttig Building Products, Inc. (NASDAQ: HBP), a leading domestic distributor of millwork, building materials and wood products, today announced it has entered into an agreement to amend and extend its $120 million senior secured credit facility. The amendment, among other things, increases borrowing capacity from $120 million to $160 million, reduces interest rate charges and extends the facility for five years from the execution date, to May 28, 2019. The amended facility may be increased to $200 million, through an uncommitted $40 million accordion feature, subject to certain conditions. General Electric Capital Corporation (GECC) and Wells Fargo Capital Finance, LLC (Wells Fargo) are co-lenders under the facility.
MoistureShield Composite Decking Expands Distribution Network with 12 New Distribution Locations
PRWeb - Thu Mar 20, 2:14AM CDT
MoistureShield composite decking has expanded its 2014 distributor network in the U.S. Sunbelt and West Coast regions with recent additions of: Huttig Building Products in Phoenix, Ariz.; Nashville, Tenn.; and Jackson, Miss. BlueLinx in Tampa, Miami and Jacksonville, Fla. Dixie Plywood and Lumber Company in San Antonio, Houston and Dallas, Texas Universal Forest Products in Thornton and Riverside, Calif. Intermountain Supply in Spokane, Wash.
Helix BioPharma Corp. Announces Appointment of New Director and Observer to the Board of Directors
Marketwire Canada - Tue Mar 11, 4:00PM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today announced the appointment of Mr. Sylwester Cacek to the board of directors. Mr. Cacek's appointment was effective March 7, 2014.
Huttig Building Products, Inc. Announces Fourth Quarter and Full Year 2013 Results
Marketwire - Thu Feb 20, 1:00AM CST
Huttig Building Products, Inc. (Huttig, or the Company) (NASDAQ: HBP), a leading domestic distributor of millwork, building materials and wood products, today reported financial results for the fourth quarter and year ended December 31, 2013.
Huttig Building Products, Inc. Announces Second Quarter 2014 Results
Marketwire - Thu Jul 31, 5:01AM CDT
Huttig Building Products, Inc. (Huttig, or the Company) (NASDAQ: HBP), a leading domestic distributor of millwork, building materials and wood products, today reported financial results for the second quarter ended June 30, 2014.
Helix BioPharma Corp. Appoints New Independent Chair of the Board
Marketwire Canada - Mon Jul 21, 8:15AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced the appointment of Mr. Yvon Bastien as the new Chair of the board effective July 17, 2014. Mr. Bastien has served as an independent director of the Company since December 2013 and remains the Chair of the board's Governance & Compensation Committee. Mr. Robert Verhagen has served as Interim Chair since December 2013 and remains a Director of the Company and President and CEO.
Helix BioPharma Corp. Initiates Enrollment for Ninth Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47
Marketwire - Tue Jul 15, 7:32AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced the opening of patient screening for the ninth dose level cohort in its ongoing Phase I/II clinical safety, tolerability and preliminary efficacy study of L-DOS47 in Poland ("LDOS002"
. This follows completion of the first treatment cycle in the three patients enrolled in the eighth dose level cohort, in which L-DOS47 therapy was well tolerated, as reviewed by the Trial Steering Committee. Helix BioPharma Corp. Announces Completion of Private Placement
Marketwire - Fri Jul 11, 7:00AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has completed a private placement with net proceeds in excess of CAD5.4 million, after fees and expenses associated with the placement.
Helix BioPharma Corp. Announces the Receipt of Subscription Agreements for a Net CAD5.4 Million Private Placement
Marketwire Canada - Mon Jul 07, 6:25AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has received private placement subscription agreements for common shares and warrants for aggregate net proceeds in excess of CAD5.4 million after expected expenses. Proceeds of the placement will be used for working capital to support the Company's expanding clinical trial initiatives.
Huttig Building Products, Inc. Set to Join Russell Microcap Index
Marketwire - Thu Jun 26, 3:00PM CDT
Huttig Building Products, Inc. (NASDAQ: HBP) is set to join the Russell Microcap(R) Index when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 27, according to a preliminary list of additions posted June 13 on www.russell.com/indexes.
GE Capital, Corporate Finance serves as administrative agent on USD160m credit facility for Huttig Building Product
M2 - Thu Jun 19, 3:05AM CDT
GE Capital, Corporate Finance announced on Wednesday that it is serving as administrative agent on a USD160m revolving credit facility for Huttig Building Product Inc (Nasdaq:HBP), a wholesale distributor of millwork, building materials and wood products.
GE Capital Is Administrative Agent on $160 Million Credit Facility for Huttig Building Products Inc.
Business Wire - Wed Jun 18, 7:00AM CDT
GE Capital, Corporate Finance today announced it is serving as administrative agent on a $160 million revolving credit facility for Huttig Building Product Inc. (NASDAQ:HBP). The new facility refinances existing debt and provides an additional $40 million in financing to support future growth. GE Capital Markets served as co-lead arranger.
Helix BioPharma Corp. Announces Fiscal Q3 2014 Results
Marketwire - Thu Jun 12, 8:02AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today announced financial results for the three and nine-month periods ended April 30, 2014 and 2013.
Huttig Building Products, Inc. Amends and Extends Credit Facility -- Increases Capacity to $160 Million
Marketwire - Thu May 29, 5:01AM CDT
Huttig Building Products, Inc. (NASDAQ: HBP), a leading domestic distributor of millwork, building materials and wood products, today announced it has entered into an agreement to amend and extend its $120 million senior secured credit facility. The amendment, among other things, increases borrowing capacity from $120 million to $160 million, reduces interest rate charges and extends the facility for five years from the execution date, to May 28, 2019. The amended facility may be increased to $200 million, through an uncommitted $40 million accordion feature, subject to certain conditions. General Electric Capital Corporation (GECC) and Wells Fargo Capital Finance, LLC (Wells Fargo) are co-lenders under the facility.
MoistureShield Composite Decking Expands Distribution Network with 12 New Distribution Locations
PRWeb - Thu Mar 20, 2:14AM CDT
MoistureShield composite decking has expanded its 2014 distributor network in the U.S. Sunbelt and West Coast regions with recent additions of: Huttig Building Products in Phoenix, Ariz.; Nashville, Tenn.; and Jackson, Miss. BlueLinx in Tampa, Miami and Jacksonville, Fla. Dixie Plywood and Lumber Company in San Antonio, Houston and Dallas, Texas Universal Forest Products in Thornton and Riverside, Calif. Intermountain Supply in Spokane, Wash.
Helix BioPharma Corp. Announces Appointment of New Director and Observer to the Board of Directors
Marketwire Canada - Tue Mar 11, 4:00PM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today announced the appointment of Mr. Sylwester Cacek to the board of directors. Mr. Cacek's appointment was effective March 7, 2014.
Huttig Building Products, Inc. Announces Fourth Quarter and Full Year 2013 Results
Marketwire - Thu Feb 20, 1:00AM CST
Huttig Building Products, Inc. (Huttig, or the Company) (NASDAQ: HBP), a leading domestic distributor of millwork, building materials and wood products, today reported financial results for the fourth quarter and year ended December 31, 2013.
